Back

Utility of the HFA-PEFF score in patients with sick sinus syndrome after pacemaker implantation for predicting outcomes

29 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Setting the pace: an inside look at pacing therapy Sinus Node Dysfunction ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hironobu Sumiyoshi

Kameda Medical Center, Kamogawa (Japan)

7 More presentations in this session

Presentation thumbnail
Upgrading to cardiac resynchronization therapy: who truly reaps the benefits?
Doctor B. Andrade (Santarem, PT)
Abstract Slides Video
Presentation thumbnail
Transvenous lead extraction of abandoned vs functional leads: a systematic review and meta-analysis of procedural and long-term clinical outcomes
Doctor K. Chauhan (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Microplastics in septum after left bundle branch pacing: evidence from animal experiment
Doctor Y. Hu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of heart failure hospitalization in patients with the first marketed leadless pacemaker -micra VR
Doctor M. Matsumura (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Long term real world performance of the micra leadless pacemaker: a single-center study
Doctor F. Mendez Zurita (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Setting the pace: an inside look at pacing therapy

The Event

Event poster

ESC Congress 2025

29 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
An alternative clinical score for the diagnosis of heart failure with preserved left ventricular ejection fraction in patients with atrial fibrillation
thumbnail
Congress Presentation
Comparing diagnostic accuracy of HFA-PEFF score vs. ESC guidelines definition of heart failure with preserved ejection fraction: findings from a pacemaker systematic screening program
thumbnail
Congress Presentation
Impact of HFA-PEFF score in predicting outcomes of patients with coronary artery disease across the range of ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources